American Journal of Hematology

• 

  Publication Venue For

  • Patient-reported neurocognitive symptoms influence instrumental activities of daily living in sickle cell disease..  96:1396-1406. 2021
  • Diffuse large B-cell lymphoma with primary treatment failure: Ultra-high risk features and benchmarking for experimental therapies.  92:e24615-e24615. 2017
  • PREDICTORS OF MAJOR BLEEDING DURING WARFARIN INTERRUPTION FOR INVASIVE PROCEDURES: ANALYSIS OF THE BRIDGE TRIAL.  91:E391-E391. 2016
  • THROMBOCYTOPENIA IN HOSPITALIZED NON-ICU PATIENTS.  91:E401-E401. 2016
  • EFFECTS OF DENTAL CARE ON ACUTE CARE UTILIZATION FOR INDIVIDUALS WITH SICKLE CELL DISEASE.  88:E64-E64. 2013
  • EMERGENCY PROVIDER ATTITUDES TOWARDS SICKLE CELL PATIENTS.  88:E28-E29. 2013
  • IMPROVING QUALITY OF CARE FOR SICKLE CELL PATIENTS IN THE PEDIATRIC EMERGENCY DEPARTMENT.  88:E12-E13. 2013
  • PATIENTS WITH SICKLE CELL DISEASE REPORT POORER COMMUNICATION THAN NATIONAL ESTIMATES OF AFRICAN-AMERICANS' EXPERIENCES.  88:E25-E25. 2013
  • Primary Care Providers Comfort Levels in Caring for Patients with Sickle Cell Disease.  88:E32-E33. 2013
  • SOCIAL BEHAVIORAL NEEDS OF PATIENTS WITH SICKLE CELL DISEASE.  88:E46-E46. 2013
  • UTILIZATION OF SOCIAL MEDIAS AND ITS IMPACT ON PATIENT AND PROVIDER SICKLE CELL EDUCATION.  88:E32-E32. 2013
  • VARIATION IN THE TREATMENT OF STROKE IN SICKLE CELL DISEASE: A SURVEY OF PROVIDERS.  88:E2-E2. 2013
  • Corrigendum.  88:632-632. 2013
  • Among emergency physicians, use of the term "Sickler" is associated with negative attitudes toward people with sickle cell disease..  88:532-533. 2013
  • INACTIVATION OF TRANSFERRIN RECEPTOR (TFR1) IN THE PANCREAS RESULTS IN PANCREATITIS AND DIABETES.  88:E197-E197. 2013
  • RETINAL IRON DYSREGULATION IN SYSTEMIC OR CONDITIONAL KNOCKOUT MOUSE MODELS OF HUMAN DISEASE: PROTECTION BY IRON CHELATION.  88:E34-E34. 2013
  • TRANSFERRIN RECEPTOR 1 (TFR1) IS REQUIRED FOR MAINTENANCE OF THE INTESTINAL EPITHELIUM.  88:E12-E13. 2013
  • Antithrombin Levels Are Significantly Lower During Pregnancy.  87:S193-S193. 2012
  • Changes in Thrombin Generation During Pregnancy as Measured by Computerized Automated Thrombography (Cat).  87:S170-S170. 2012
  • Consumption of Antithrombin at Delivery.  87:S168-S168. 2012
  • Erratum: Costs and length of stay for patients with and without sickle cell disease after hysterectomy, appendectomy, or knee replacement.  86:903. 2011
  • Erratum: Outcomes of inpatients with and without sickle cell disease after high-volume surgical procedures.  86:906-908. 2011
  • Comparison of characteristics from White- and Black-Americans with venous thromboembolism: A cross sectional study.  85:908-908. 2010
  • Erratum: “Corticosteroids for acute chest syndrome in children with sickle cell disease: Variation in use and association with length of stay and readmission” by Sobota et al.,Am J Hematol 2010 DOI number 21565.  85:399-399. 2010
  • C/EBPA gene mutation and C/EBPA promoter hypermethylation in acute myeloid leukemia with normal cytogenetics.  NA-NA. 2010
  • Nodular lymphocyte predominant Hodgkin lymphoma at atypical locations may be associated with increased numbers of large cells and a diffuse histologic component..  83:218-221. 2008
  • Response to Boctor and Smith.  83:256. 2008
  • Utility of consecutive repeat HIT ELISA testing for heparin-induced thrombocytopenia..  83:212-217. 2008
  • Pulmonary hypertension associated with sickle cell disease: clinical and laboratory endpoints and disease outcomes..  83:19-25. 2008
  • Clinical and molecular predictors of disease severity and survival in chronic lymphocytic leukemia..  82:1063-1070. 2007
  • Thrombotic thrombocytopenic purpura induced by trimethoprim-sulfamethoxazole in a Jehovah's Witness..  82:679-681. 2007
  • Morbidity and mortality in chronically transfused subjects with thalassemia and sickle cell disease: A report from the multi-center study of iron overload..  82:255-265. 2007
  • Concurrent acute myeloid leukemia with inv(16)(p13.1q22) and chronic lymphocytic leukemia: molecular evidence of two separate diseases..  81:963-968. 2006
  • Thymoma followed by paroxysmal nocturnal hemoglobinuria: a unique clinical association in the context of multiorgan autoimmunity with a potential role for CD8+ T lymphocytes..  81:774-778. 2006
  • Erythrophagocytosis by dysplastic neutrophils in chronic myelomonocytic leukemia and subsequent transformation to acute myeloid leukemia..  79:340-342. 2005
  • T-cell-mediated pure red-cell aplasia in systemic lupus erythematosus: response to cyclosporin A and mycophenolate mofetil..  78:161-163. 2005
  • B-CAM/LU expression and the role of B-CAM/LU activation in binding of low- and high-density red cells to laminin in sickle cell disease..  75:63-72. 2004
  • High-dose cyclophosphamide and etoposide for patients with refractory acute myeloid leukemia: a case series..  73:295-296. 2003
  • Serum homocysteine, thermolabile variant of methylene tetrahydrofolate reductase (MTHFR), and venous thromboembolism: Longitudinal Investigation of Thromboembolism Etiology (LITE)..  72:192-200. 2003
  • Factor XIII deficiency mistaken for battered child syndrome: case of "correct" test ordering negated by a commonly accepted qualitative test with limited negative predictive value..  71:328-330. 2002
  • Frequency of anti-heparin-platelet factor 4 antibodies in hemodialysis patients and correlation with recurrent vascular access thrombosis..  69:72-73. 2002
  • Mutation of bcl-x gene in non-Hodgkin's lymphoma..  69:74-76. 2002
  • Coagulation factor XI is a contaminant in intravenous immunoglobulin preparations.  65:30-34. 2000
  • Coagulation factor XI is a contaminant in intravenous immunoglobulin preparations..  65:30-34. 2000
  • Pneumococcal vaccine administration associated with splenectomy: the need for improved education, documentation, and the use of a practical checklist..  65:25-29. 2000
  • Binding of HMG-I(Y) elicits structural changes in a silencer of the human beta-globin gene..  60:27-35. 1999
  • Plasma fibronectin during myocardial ischemia-reperfusion: effects of magnesium, diltiazem, and a novel Mac-1 inhibitor..  57:309-314. 1998
  • Infectious morbidity in long-term survivors of allogeneic marrow transplantation is associated with low CD4 T cell counts..  54:131-138. 1997
  • Acquired hypoprothrombinemia: effects of danazol treatment..  53:272-276. 1996
  • Thrombocytopenia in association with a wandering spleen..  53:259-263. 1996
  • Opportunistic pulmonary infections with fludarabine in previously treated patients with low-grade lymphoid malignancies: a role for Pneumocystis carinii pneumonia prophylaxis..  49:135-142. 1995
  • Reticulated platelet counts in patients undergoing autologous bone marrow transplantation: an aid in assessing marrow recovery..  46:319-324. 1994
  • Spontaneous factor VIII inhibitor occurring in association with chronic graft-versus-host disease..  45:240-243. 1994
  • Topical thrombin and acquired coagulation factor inhibitors: clinical spectrum and laboratory diagnosis..  45:128-135. 1994
  • Dyshematopoiesis in combined immune deficiency with congenital neutropenia..  45:63-72. 1994
  • Mean platelet volume improves upon the megathrombocyte index but cannot replace the blood film examination in the evaluation of thrombocytopenia..  44:89-94. 1993
  • Platelet activation in patients with thrombotic thrombocytopenic purpura..  42:182-185. 1993
  • Pelger-Huet anomaly in an infant with multiple congenital anomalies..  38:240-242. 1991
  • Erythrocyte Webb-type glycophorin C variant lacks N-glycosylation due to an asparagine to serine substitution..  37:51-52. 1991
  • Regulation of tissue plasminogen activator in sickle cell anemia..  35:167-170. 1990
  • Human immunodeficiency virus-1 disease progression in hemophiliacs..  34:204-209. 1990
  • High-dose intravenous methylprednisolone for Kasabach-Merritt syndrome..  31:219-220. 1989
  • Elevated urokinase-type plasminogen activator level and bleeding in amyloidosis: case report and literature review..  31:53-57. 1989
  • Trephine needle bone marrow biopsy in the initial staging of Hodgkin disease: sensitivity and specificity of the Ann Arbor staging procedure criteria..  30:115-120. 1989
  • Author's reply.  31:220-220. 1989
  • Antifibrinolytic therapy in the management of the Kasabach Merritt syndrome..  29:44-48. 1988
  • Defective release of tissue plasminogen activator in patients with sickle cell anemia..  29:52-53. 1988
  • Transmission of human immunodeficiency virus to sexual partners of hemophiliacs..  28:27-32. 1988
  • Congenital Pelger-Huet anomaly in triplets..  27:226-227. 1988
  • Role of immune stimulation in the etiology of multiple myeloma: a case control study..  24:119-126. 1987
  • Treatment of red cell aplasia with antithymocyte globulin: repeated inductions of complete remissions in two patients..  20:183-186. 1985
  • Marrow transplantation in hepatitis-associated aplastic anemia..  17:269-278. 1984
  • Analysis of T-cell subsets in B-cell chronic lymphocytic leukemia: a correlation with the stage of disease..  16:67-73. 1984
  • Unique sensitivity of Hb Zürich to oxidative injury by phenazopyridine: reversal of the effects by elevating carboxyhemoglobin levels in vivo and in vitro..  14:315-324. 1983
  • Prednisone-responsive aplastic anemia associated with T-lymphocyte proliferation..  11:293-298. 1981
  • Myelomatous pleural effusion: clinical course and immunologic characterization of the pleural fluid cells..  6:267-273. 1979
  • The kinetics of immunoglobulin synthesis by pokeweed mitogen stimulated peripheral blood lymphocytes in multiple myeloma..  6:361-371. 1979
  • Corticosteroid-induced lymphocytopenia in man: absence of splenic influence and effect of recipient serum..  4:255-259. 1978
  • Relapse following marrow transplantation for acute leukemia..  5:191-202. 1978
  • The lipids of the erythrocyte in paroxysmal nocturnal hemoglobinuria..  5:323-333. 1978
  • Acute myelogenous leukemia subsequent to therapy for a different neoplasm: clinical features and response to therapy..  3:209-218. 1977
  • Depletion of Large Granular Lymphocytes in A First-in-Human Clinical Trial of ABC008 2021
  • REAL-WORLD PATTERNS OF ROMIPLOSTIM TREATMENT IN ADULTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA IN THE UNITED STATES 2018
  • TISSUE-AUTONOMOUS REGULATION OF RETINAL IRON TRANSPORT 2017
  • AN UNUSUAL PRESENTATION OF CONGENITAL PROTEIN C DEFICIENCY 2016
  • Whole-Blood Gene Expression Profiles Can Distinguish Patients with Cancer and Venous Thromboembolism from Patients with Venous Thromboembolism Only 2012